|
1
|
Kobayashi N, Saito Y, Uraoka T, Matsuda T,
Suzuki H and Fujii T: Treatment strategy for laterally spreading
tumors in Japan: Before and after the introduction of endoscopic
submucosal dissection. J Gastroenterol Hepatol. 24:1387–1392. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beaton C, Twine CP, Williams GL and
Radcliffe AG: Systematic review and meta-analysis of
histopathological factors influencing the risk of lymph node
metastasis in early colorectal cancer. Colorectal Dis. 15:788–797.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki T, Sadahiro S, Mukoyama S, Ishikawa
K, Yasuda S, Tajima T, Makuuchi H and Murayama C: Risk of lymph
node and distant metastases in patients with early invasive
colorectal cancer classified as Haggitt's level 4 invasion: Image
analysis of submucosal layer invasion. Dis Colon Rectum.
46:203–208. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ueno H, Hashiguchi Y, Kajiwara Y, Shinto
E, Shimazaki H, Kurihara H, Mochizuki H and Hase K: Proposed
objective criteria for ‘grade 3’ in early invasive colorectal
cancer. Am J Clin Pathol. 134:312–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Benizri EI, Bereder JM, Rahili A, Bernard
JL, Vanbiervliet G, Filippi J, Hébuterne X and Benchimol D:
Additional colectomy after colonoscopic polypectomy for T1 colon
cancer: A fine balance between oncologic benefit and operative
risk. Int J Colorectal Dis. 27:1473–1478. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roeb E, Arndt M, Jansen B, Schumpelick V
and Matern S: Simultaneous determination of matrix
metalloproteinase (MMP)-7, MMP-1, −3, and −13 gene expression by
multiplex PCR in colorectal carcinomas. Int J Colorectal Dis.
19:518–524. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ii M, Yamamoto H, Adachi Y, Maruyama Y and
Shinomura Y: Role of matrix metalloproteinase-7 (matrilysin) in
human cancer invasion, apoptosis, growth, and angiogenesis. Exp
Biol Med (Maywood). 231:20–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adachi Y, Yamamoto H, Itoh F, Arimura Y,
Nishi M, Endo T and Imai K: Clinicopathologic and prognostic
significance of matrilysin expression at the invasive front in
human colorectal cancers. Int J Cancer. 95:290–294. 2001.PubMed/NCBI
|
|
9
|
Watanabe T, Itabashi M, Shimada Y, Tanaka
S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, et
al: Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2010 for the treatment of colorectal cancer. Int J Clin
Oncol. 17:1–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kudo S, Lambert R, Allen JI, Fujii H,
Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, et al:
Nonpolypoid neoplastic lesions of the colorectal mucosa.
Gastrointest Endosc. 68(4 Suppl): S3–S47. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hamilton SR, Bosman FT, Boffetta P, Ilyas
M, Morreau H and Nakamura SI: WHO classification of tumours of the
digestive systemCarcinoma of the colon and rectum. Bosman FT,
Carneiro F, Hruban RH and Theise ND: International Agency for
Research on Cancer (IARC); Lyon: pp. 134–146. 2010
|
|
12
|
Ueno H, Murphy J, Jass JR, Mochizuki H and
Talbot IC: Tumour ‘budding’ as an index to estimate the potential
of aggressiveness in rectal cancer. Histopathology. 40:127–132.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ueno H, Mochizuki H, Hashiguchi Y,
Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kurihara H,
Ozawa K, et al: Risk factors for an adverse outcome in early
invasive colorectal carcinoma. Gastroenterology. 127:385–394. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shimoda T, Ikegami M, Fujisaki J, Matsui
T, Aizawa S and Ishikawa E: Early colorectal carcinoma with special
reference to its development de novo. Cancer. 64:1138–1146. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kudo S: Endoscopic mucosal resection of
flat and depressed types of early colorectal cancer. Endoscopy.
25:455–461. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kashida H and Kudo SE: Early colorectal
cancer: Concept, diagnosis, and management. Int J Clinical Oncol.
11:1–8. 2006. View Article : Google Scholar
|
|
17
|
Miyachi H, Kudo SE, Ichimasa K, Hisayuki
T, Oikawa H, Matsudaira S, Kouyama Y, Kimura YJ, Misawa M, Mori Y,
et al: Management of T1 colorectal cancers after endoscopic
treatment based on the risk stratification of lymph node
metastasis. J Gastroenterol Hepatol. 31:1126–1132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Masaki T, Matsuoka H, Sugiyama M, Abe N,
Goto A, Sakamoto A and Atomi Y: Matrilysin (MMP-7) as a significant
determinant of malignant potential of early invasive colorectal
carcinomas. Br J Cancer. 84:1317–1321. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kurokawa S, Arimura Y, Yamamoto H, Adachi
Y, Endo T, Sato T, Suga T, Hosokawa M, Shinomura Y and Imai K:
Tumour matrilysin expression predicts metastatic potential of stage
I (pT1) colon and rectal cancers. Gut. 54:1751–1758. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tamahashi U, Kumagai J, Takizawa T, Sekine
M and Eishi Y: Expression and intracellular localization of matrix
metalloproteinases in intraductal papillary mucinous neoplasms of
the pancreas. Virchows Arch. 453:79–87. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barros SS, Henriques ÁC, Pereira KM, de
Medeiros AM, Galvão HC and Freitas Rde A: Immunohistochemical
expression of matrix metalloproteinases in squamous cell carcinoma
of the tongue and lower lip. Arch Oral Biol. 56:752–760. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gilardoni E, Bernasconi DP, Poli S,
Garancini M, Luperto M, Zucchini N, Bovo G, Totis M, Bugatti A and
Gianotti L: Surveillance for early stages of colon cancer:
Potentials for optimizing follow-up protocols. World J Surg Oncol.
13:2602015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho K, Matsuda Y, Ueda J, Uchida E, Naito
Z and Ishiwata T: Keratinocyte growth factor induces matrix
metalloproteinase-9 expression and correlates with venous invasion
in pancreatic cancer. Int J Oncol. 40:1040–1048. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sekiuchi M, Kudo A, Nakabayashi K,
Kanai-Azuma M, Akimoto Y, Kawakami H and Yamada A: Expression of
matrix metalloproteinases 2 and 9 and tissue inhibitors of matrix
metalloproteinases 2 and 1 in the glomeruli of human glomerular
diseases: The results of studies using immunofluorescence, in situ
hybridization, and immunoelectron microscopy. Clin Exp Nephrol.
16:863–874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Masuda Y, Yamanaka N, Ishikawa A, Kataoka
M, Arai T, Wakamatsu K, Kuwahara N, Nagahama K, Ichikawa K and
Shimizu A: Glomerular basement membrane injuries in IgA nephropathy
evaluated by double immunostaining for α5(IV) and α2(IV) chains of
type IV collagen and low-vacuum scanning electron microscopy. Clin
Exp Nephrol. 19:427–435. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harrell PC, McCawley LJ, Fingleton B,
McIntyre JO and Matrisian LM: Proliferative effects of apical, but
not basal, matrix metalloproteinase-7 activity in polarized MDCK
cells. Exp Cell Res. 303:308–320. 2005. View Article : Google Scholar : PubMed/NCBI
|
